Reclassification of cannabis and cannabis resin will remove some international procedural barriers to research and growth of cannabis-centered clinical goods In keeping with countrywide regulatory frameworks.  The improve in status of cannabis will not impact its non-professional medical use or market legalization, because it remains under strict